Variant report

Variant	rs641053
Chromosome Location	chr1:212662049-212662050
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr1:212654477..212657612-chr1:212658521..212662499,5	K562	blood:
2	chr1:212661275..212664884-chr1:212673911..212677045,3	K562	blood:
3	chr1:212648507..212667078-chr1:212779147..212787651,52	K562	blood:
4	chr1:212660685..212662687-chr1:212682544..212685415,2	K562	blood:
5	chr1:212645024..212669819-chr1:212778382..212791615,68	K562	blood:
6	chr1:212661862..212663764-chr1:212729767..212731611,2	K562	blood:

Variant related genes	Relation type
ENSG00000162772	Chromatin interaction
ENSG00000264590	Chromatin interaction
ENSG00000260805	Chromatin interaction

Extended variants
information (count: 36 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:24)

rs_ID	r²[population]
rs1126526	1.00[CHB][hapmap]
rs12739715	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs17019266	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs17019397	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs17019510	1.00[CHB][hapmap]
rs2007776	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs2456815	1.00[ASN][1000 genomes]
rs3001261	1.00[ASN][1000 genomes]
rs35030678	1.00[ASN][1000 genomes]
rs492231	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs498564	1.00[AFR][1000 genomes];1.00[ASN][1000 genomes]
rs536040	1.00[CHB][hapmap];1.00[YRI][hapmap]
rs56085986	1.00[ASN][1000 genomes]
rs592459	1.00[AFR][1000 genomes]
rs593750	1.00[ASN][1000 genomes]
rs648577	1.00[ASN][1000 genomes]
rs6680374	1.00[ASN][1000 genomes]
rs71646161	1.00[ASN][1000 genomes]
rs74138553	1.00[ASN][1000 genomes]
rs74138559	1.00[ASN][1000 genomes]
rs7530106	1.00[ASN][1000 genomes]
rs7549085	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs7551910	1.00[ASN][1000 genomes]
rs9429888	1.00[CHB][hapmap]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1009376	chr1:212292357-212680320	Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Active TSS ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	48 gene(s)	inside rSNPs	diseases
2	nsv549139	chr1:212332294-212876902	Flanking Active TSS Weak transcription Bivalent Enhancer Strong transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	114 gene(s)	inside rSNPs	diseases
3	nsv1013110	chr1:212555764-212948092	Flanking Active TSS Bivalent/Poised TSS Strong transcription Enhancers Bivalent Enhancer Weak transcription ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	81 gene(s)	inside rSNPs	diseases
4	nsv535287	chr1:212555764-212948092	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Active TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	81 gene(s)	inside rSNPs	diseases
5	nsv873159	chr1:212610755-212669475	Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
6	nsv873160	chr1:212610755-212675482	Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
7	nsv873161	chr1:212610755-212683565	Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
8	nsv873162	chr1:212610755-212716033	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Strong transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
9	nsv527863	chr1:212617423-212700618	Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
10	nsv873163	chr1:212629935-212669475	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
11	esv2757770	chr1:212648143-212843103	Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	77 gene(s)	inside rSNPs	diseases
12	esv2758996	chr1:212648143-212843103	Enhancers Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription Strong transcription Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	77 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:72 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:212650600-212667800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr1:212655000-212665800	Enhancers	Placenta	Placenta
3	chr1:212655200-212662800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr1:212655600-212662200	Weak transcription	Right Atrium	heart
5	chr1:212656800-212662200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
6	chr1:212657200-212664800	Weak transcription	Spleen	Spleen
7	chr1:212658000-212662800	Enhancers	Breast Myoepithelial Primary Cells	Breast
8	chr1:212658000-212663000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr1:212658000-212663000	Enhancers	Stomach Mucosa	stomach
10	chr1:212658200-212663000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr1:212660000-212662200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr1:212660000-212662200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr1:212660000-212662200	Weak transcription	Skeletal Muscle Male	skeletal muscle
14	chr1:212660000-212662200	Weak transcription	NHDF-Ad	bronchial
15	chr1:212660000-212662400	Weak transcription	Esophagus	oesophagus
16	chr1:212660000-212664200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr1:212660200-212662200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
18	chr1:212660200-212662200	Weak transcription	NH-A	brain
19	chr1:212660200-212662400	Weak transcription	Pancreas	Pancrea
20	chr1:212660200-212663400	Enhancers	Hela-S3	cervix
21	chr1:212660200-212663600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
22	chr1:212661200-212663000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr1:212661200-212665800	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr1:212661400-212662600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr1:212661400-212662800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr1:212661400-212662800	Enhancers	Colon Smooth Muscle	Colon
27	chr1:212661400-212662800	Enhancers	Lung	lung
28	chr1:212661400-212662800	Flanking Active TSS	A549	lung
29	chr1:212661400-212662800	Enhancers	HSMMtube	muscle
30	chr1:212661400-212663000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr1:212661400-212663000	Enhancers	Fetal Stomach	stomach
32	chr1:212661400-212663200	Enhancers	Fetal Intestine Large	intestine
33	chr1:212661400-212663200	Enhancers	Fetal Intestine Small	intestine
34	chr1:212661400-212664000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr1:212661400-212664200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr1:212661400-212664200	Enhancers	Brain Substantia Nigra	brain
37	chr1:212661400-212664600	Enhancers	Brain Hippocampus Middle	brain
38	chr1:212661400-212664600	Enhancers	Monocytes-CD14+_RO01746	blood
39	chr1:212661600-212662400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr1:212661600-212662400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr1:212661600-212662600	Enhancers	Placenta Amnion	Placenta Amnion
42	chr1:212661600-212662800	Enhancers	Aorta	Aorta
43	chr1:212661600-212662800	Enhancers	HMEC	breast
44	chr1:212661600-212663000	Enhancers	Adipose Nuclei	Adipose
45	chr1:212661600-212663000	Enhancers	Brain Angular Gyrus	brain
46	chr1:212661600-212663000	Enhancers	Duodenum Smooth Muscle	Duodenum
47	chr1:212661600-212663000	Enhancers	Fetal Muscle Leg	muscle
48	chr1:212661600-212663000	Enhancers	Rectal Mucosa Donor 31	rectum
49	chr1:212661600-212663000	Enhancers	K562	blood
50	chr1:212661600-212663000	Enhancers	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links